De Novo device
Triage B-Type Natriuretic Peptide (Bnp) Test
Biosite Incorporated · Test, Natriuretic Peptide (NBC, Class II) · First FDA decision Nov 20, 2000, newest Jul 1, 2002Heart attack and heart failure blood testsHeart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
De Novo pathway
Device trials
1
Naming "Triage B-Type"
MAUDE reports
0
Brand "Triage B-Type", since 2015
PubMed studies
4
Mentioning "Triage B-Type"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Triage B-Type Natriuretic Peptide (Bnp) Test
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K021317 · Decided Jul 1, 2002 · 67 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL33573Wellpoint FederalUpdated Jul 14, 2026
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL35526Noridian Healthcare Solutions, LLCUpdated Feb 23, 2026
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL34410Palmetto GBAUpdated Dec 22, 2025
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL33943CGS Administrators, LLCUpdated Nov 26, 2025
- B-type Natriuretic Peptide (BNP) TestingProposed local determinationProposedDL34410Palmetto GBAUpdated Jan 31, 2025
- B-Type Natriuretic Peptide (BNP)Local determinationIn effectL33267First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Triage B-Type", any status and sponsor, newest update first.
- Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)Pivotal-lookingTerminated
Abbott RDx CardiometabolicAcademic, hospital or other
NCT00206856 · 720 participants · Start Jul 2003 · Primary completion Apr 2006
Device: Triage® B-Type Natriuretic Peptide (BNP) Test · For: Heart Failure
Sites: Scottsdale, Arizona; San Diego, California; San Francisco, California · 29 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Triage B-Type", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NBC
183 reports: 178 malfunction, 5 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Triage B-Type"[tiab]. The summary above synthesizes these.
- Unexpected Interference on Alere Triage B-Type Natriuretic Peptide Measurement.
Tecleab A, Miller L, Brewster A, et al. · J Appl Lab Med · 2017
- Plasma brain natriuretic peptide levels in patients with rheumatic heart disease.
Gölbaşý Z, Uçar O, Yüksel AG, et al. · Eur J Heart Fail · 2004
- Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker.
Mehra MR, Uber PA, Walther D, et al. · Circulation · 2006Research Support, Non-U.S. Gov't
- The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis.
Eryol NK, Dogan A, Ozdogru I, et al. · Int J Cardiovasc Imaging · 2007Comparative Study, Evaluation Study
Other devices of this type
Also filed under product code NBC.
- Elecsys proBNP II, Elecsys proBNP II STATRoche Diagnostics · 510(k) 2023
- Triage Bnp Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated · 510(k) 2006
- Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 510(k) 2005
- Access BNP IIBeckman Coulter, Inc. · 510(k) 2026
- Access NT-proBNPBeckman Coulter, Inc. · 510(k) 2026
- Alere NT-proBNP for Alinity iAxis-Shield Diagnostics, Ltd. · 510(k) 2026
- VITROS Immunodiagnostic Products NT-proBNP II Reagent PackOrtho Clinical Diagnostics · 510(k) 2021
- Stratus Cs Acute Care Nt-Probnp Testpak, Model CpbnpmDade Behring, Inc. · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.